Close Menu

NEW YORK ─ Hauppauge, New York-based Chembio Diagnostics announced on Thursday that it has received CE marking for its DPP SARS-CoV-2 Antigen and IgM/IgG test systems, enabling their marketing in the European Union and other regions that accept the designation.

The company also announced that it has entered into a distribution agreement with Guildford, UK-based Luas Diagnostics, which will commence system sales and serve as the exclusive commercial partner for all Chembio products in the UK and Ireland.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.